KLK3 and prostate cancer: In a single case study, Kojima et al18 reported that a patient with recurrent prostate cancer whose PSA declined from >5 mg/mL to near non-detectable levels (0.085 mg/mL) after 6 weekly fractions of 150 mGy of radiation.